Risk and Benefit for Targeted Therapy Agents in Pediatric Phase II Trials in Oncology: A Systematic Review with a Meta-Analysis

por Strzebonska, Karolina, Wasylewski, Mateusz T., Zaborowska, Lucja, Polak, Maciej, Slugocka, Emilia, Stras, Jakub, Blukacz, Mateusz, Gyawali, Bishal, Waligora, Marcin
Publicado 2021

Binding mechanism and biological effects of flavone DYRK1A inhibitors for the design of new antidiabetics

por Pustelny, Katarzyna, Grygier, Przemyslaw, Barzowska, Agata, Pucelik, Barbara, Matsuda, Alex, Mrowiec, Krzysztof, Slugocka, Emilia, Popowicz, Grzegorz M., Dubin, Grzegorz, Czarna, Anna
Publicado 2023

Serotonin 5-HT(6) Receptor Ligands and Butyrylcholinesterase Inhibitors Displaying Antioxidant Activity—Design, Synthesis and Biological Evaluation of Multifunctional Agents agains...

por Więckowski, Krzysztof, Szałaj, Natalia, Gryzło, Beata, Wichur, Tomasz, Góral, Izabella, Sługocka, Emilia, Sniecikowska, Joanna, Latacz, Gniewomir, Siwek, Agata, Godyń, Justyna, Bucki, Adam, Kołaczkowski, Marcin, Więckowska, Anna
Publicado 2022